News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Market indicators show rising stress as oil, rates and AI sector strains converge.
  • President Trump said talks with Iran were 'good' but warned U.S. forces could strike fortified Pickaxe Mountain if talks fail.
  • Senators struck a bipartisan deal to expand energy sanctions and allow presidential tariffs on major buyers of Russian crude and gas.
  • France recorded its first pyrocumulonimbus as wildfires displace hundreds of thousands and strain the tourism economy.
  • Record sargassum bloom inundates Mexico's Caribbean beaches, forcing resort closures and hitting local tourism businesses.
  • Corn futures rose after USDA cut the U.S. corn good-to-excellent rating to 63%.
  • FEMSA reported Q2 revenue up 9.3% and operating income up 7.2%, led by double-digit OXXO Mexico growth.

Latest Articles

Albemarle CEO Sells Stock Despite Strong Quarterly Earnings Report

Albemarle CEO Sells Stock Despite Strong Quarterly Earnings Report

J Kent Masters, Chairman and CEO of Albemarle Corp, divested a total value of $3.0 million in company stock on May 15, 2026. This sale occurred against a backdrop of strong financial reporting for the first quarter of 2026, where Albemarle significantly beat analyst expectations for both earnings per share and revenue.

RingCentral CFO's Trading Activity and Q1 Results Provide Mixed Signals

RingCentral CFO's Trading Activity and Q1 Results Provide Mixed Signals

The Chief Financial Officer of RingCentral, Inc., Vaibhav Agarwal, conducted several transactions involving the company's Class A Common Stock in May 2026. These trades included a sale executed under a pre-arranged trading plan and an exempt disposition related to vested restricted stock units (RSUs). Separately, RingCentral reported first quarter …

Relay Therapeutics Plans $175M Share Sale as Stock Dips After Hours

Relay Therapeutics Plans $175M Share Sale as Stock Dips After Hours

Relay Therapeutics disclosed an underwritten public offering of common stock intended to raise $175 million, prompting a roughly 2% decline in its shares during after-hours trading. The company said it will sell all shares in the proposed offering and will give underwriters a 30-day option to buy up to an additional 15% of the shares. The deal is s…

Director's Buying Spree at American Vanguard Amid Market Concerns

Director's Buying Spree at American Vanguard Amid Market Concerns

American Vanguard Corp director Patrick Gottschalk recently increased his personal stake in the company through open market purchases. This insider buying activity occurs against a backdrop of mixed financial signals, including strong first-quarter revenue results but also noted challenges such as significant debt burdens and negative profitability…

Executive Transactions and Operational Updates at Alignment Healthcare

Executive Transactions and Operational Updates at Alignment Healthcare

Alignment Healthcare's President, Dawn Maroney, executed a sale of common stock totaling $482,565 on May 15, 2026. This transaction was conducted under a Rule 10b5-1 trading plan. Beyond the reported stock activity, the company disclosed positive first-quarter 2026 earnings that surpassed expectations and announced key leadership shifts.

Ibotta Director Sells Significant Shares Amid Mixed Financial Signals

Ibotta Director Sells Significant Shares Amid Mixed Financial Signals

Director Thomas D. Lehrman executed multiple transactions selling 75,907 shares of Ibotta's Class A Common Stock across May 15 and May 18, totaling approximately $2.36 million. These sales occurred even as the company's stock price has risen significantly year-to-date. The recent activity follows a period marked by mixed financial results for Q1 20…

Robinhood CFO Conducts Stock Sales Under Pre-Arrangement

Robinhood CFO Conducts Stock Sales Under Pre-Arrangement

Robinhood Markets' Chief Financial Officer, Shiv Verma, executed a series of stock sales totaling $420,535 in Class A Common Stock on May 15, 2026. These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan. Separately, the company reported robust operational data for April, including an increase in funded customers and total p…

Roblox Authorizes $3 Billion Buyback; After-Hours Stock Jump Follows

Roblox Authorizes $3 Billion Buyback; After-Hours Stock Jump Follows

Roblox Corporation's board approved its inaugural share repurchase program, authorizing up to $3 billion in buybacks and signaling plans to repurchase as much as $1 billion in the coming 12 months. The announcement drove a roughly 5% increase in the company's shares in after-hours trading. The program is designed to counteract dilution from employe…

Golar LNG Limited: 2026 AGM Results Notification

Golar LNG Limited: 2026 AGM Results Notification

Golar LNG Limited held its 2026 Annual General Meeting on May 19, 2026, where the audited financial statements for the year ended December 31, 2025, were presented. The meeting resulted in the re-election of all directors, the authorization to fill casual vacancies on the Board, reappointment of Ernst & Young LLP as auditors, and approval of direct…

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on breast cancer therapies, will participate in multiple investor conferences including TD Cowen Oncology Innovation Summit, Jefferies Global Healthcare Conference, and Goldman Sachs Global Healthcare Conference. The company highlights its lead candidate palazestrant in Phase…

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)

Eton Pharmaceuticals has entered into an agreement with Knight Therapeutics to obtain exclusive U.S. commercialization rights for IMPAVIDO® (miltefosine), the first FDA-approved oral therapy for various forms of leishmaniasis, effective September 2026. This expansion aligns with Eton’s focus on rare diseases and strengthens its portfolio with a cri…

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Cadrenal Therapeutics, a late-stage biopharmaceutical company focused on immune and thrombotic disorders, will participate in the Lytham Partners Spring 2026 Investor Conference with a webcast presentation and one-on-one investor meetings. The company highlights its lead drug candidate CAD-1005, a first-in-class 12-LOX inhibitor for treating hepari…

Toll Brothers Reports FY 2026 Second Quarter Results

Toll Brothers Reports FY 2026 Second Quarter Results

Toll Brothers, Inc., a leading U.S. luxury homebuilder, reported Q2 FY 2026 results showing a decrease in net income and earnings per share compared to the prior year quarter, despite strong home sales revenues and an increase in net signed contract value. The company raised its full-year guidance, increased dividend and share repurchases, and expa…

Aura Announces its 2025 Sustainability Report

Aura Announces its 2025 Sustainability Report

Aura Minerals Inc. announced its 2025 Sustainability Report detailing significant progress in safety, environmental stewardship, community engagement, and operational innovation. Key achievements include the implementation of water reuse in Brazil, post-mining land restoration into vineyards in Honduras, waste repurposing for agricultural use in Br…

Toronto market edges lower as materials and clean-technology names slide

Toronto market edges lower as materials and clean-technology names slide

The S&P/TSX Composite finished the session 0.27% lower in Toronto, paced by declines in Materials, Healthcare and Clean Technology sectors. A handful of names rallied strongly, including goeasy, Strathcona Resources and Thomson Reuters, while several precious-metals miners posted double-digit losses. Volatility measures ticked higher and major comm…

Brazilian equities retreat at close as Bovespa posts 1.52% drop

Brazilian equities retreat at close as Bovespa posts 1.52% drop

Brazil's Bovespa closed lower on Tuesday, sliding 1.52% to a fresh three-month trough as losses in Financials, Real Estate and Public Utilities sectors outweighed gains in select stocks. Decliners outnumbered advancers by a wide margin, with heavyweight names among the session's worst performers. Commodities and currency moves accompanied the equit…